Eficácia da MDT no tratamento de pacientes hansenianos paucibacilares - resultados preliminares

João Carlos AVELLEIRA; Alfredo Boechat MARQUES; Francisco R. VIANA; Vera Lúcia Gomes de ANDRADE

doi:10.47878/hi.1989.v14.36497

Authors

João Carlos AVELLEIRA Médico, Hospital Estadual de Curupaiti, Rio de Janeiro, RJ, Brasil.
Alfredo Boechat MARQUES Médico, Hospital Estadual de Curupaiti, Rio de Janeiro, RJ, Brasil.
Francisco R. VIANA Médico, Hospital Estadual de Curupaiti, Rio de Janeiro, RJ, Brasil.
Vera Lúcia Gomes de ANDRADE Médico, Secretaria de Estado da Saúde, Rio de Janeiro, RJ, Brasil.

DOI:

https://doi.org/10.47878/hi.1989.v14.36497

Keywords:

Hanseniasis, Paucibacillary patients, Polychemotherapy

Abstract

The efficaciousness evaluation of the polychemotherapics regimens recommended by WHO to the hansenian paucibacillary patients, is carried out mainly by the suitable follow up of patients after therapeutic discharge. The criterion for inclusion of patients as paucibacillary ones is another point of importance. The authors based on the follow up of 66 patients that completed treatment and in the abscence of relapses until the moment, advise that together with the clinical classification it should be considered factors like: the Mitsuda test, the number of lesions and the bacilloscopy result.

Downloads

Download data is not yet available.

References

1- ANDRADE, V.L.G.; MARQUES, A.B.; CUNHA, L.H.V.; AVELLEIRA, J.C.R. Feasibility of mul t idrug ther apy (MDT) in Hansen' s Disease in a urban population Curupaiti State Hospital, Rio de Janeiro, Brasil. Int. J. Leprosy, 55:435-440, 1987.
2- BRAKEL, W. ; KIST, P. ; NOBLE, S. ; O'TOOLE, L. Relapses after multidrug therapy for leprosy: a preliminary report of 22 cases in west Nepal. Lepr. Rev., 60(1): 45-50, 1989.
3- DEGUERRY, M.; DECLERCQ, E.; MISSON, C.; VELLUT, C.; BERTRAND, F. Registration of the number of macules in paucibacillary leprosy for evaluation of early diagnosis and individual prognoses. Lepr. Rev. , 60(3):206-213, 1989.
4- EKAMBARAM, V. Du r a t i o n o f t r e a tme n t f o r "disease arrest" of non-lepromatous cases and relapses rate in these patients. Lepr. Rev., 50(4): 297-302, 1979.
5- JESUDASAN, K. & CHRISTIAN, M. Ri sk of paudbacillary leprosy. Int. J. Leprosy, 53(1):19-21, 1985.
6- JESUDASAN, K. ; CHRISTIAN, M. ; BRADLEY, D. Relapse rates among non-lepromatous patientes released from control. Int. J. Leprosy, 52(3):304-310, 1984.
7- K A T O C H , K . ; RAMANATHAN, U. NATRAJAN, M. ; BAGGA, A.K. ; BHATIA, A.S. ; SAXENA, R.K. ; RAMU, G. Relapses In PB patients after treatment with three short regimens containing rifampicin. Int. J. Leprosy, 57:458-464, 1989.
8- ROSE, P. Short-course multi-drug therapy for paucibacillary patients in Guyana: preliminary communicat ion. Lepr. Rev., 55(2):143-147. 1984.
9- TALHARI, S.; CUNHA, M.G.S.; PARREIRA, J.V.; SCHETTINI, A.P.M.; CAVALCANTE, F.H.; TALHARI, A.C. Resultados preliminares com o esquema OMS/81, em pacientes tuberculóides e indeterminados. An. Bras. Dermatol,63(suppl. 1):284-286, 1988.
1 0 - TO UW- L A NG E NDI J K , E .M. J . & NA A F S , B. Relapse in leprosy after release from control. Lepr. Rev., 5012):123-127, 1979.
1 1 - W O R L D H E A L T H O R G A N I Z A T I O N . Chemotherapy of Leprosy for Cont rol Programmes: r epor t of a WHO s tudy g r o u p . G e n e v a , 1 9 8 2 . 3 6 p . (WH O . Technical report series, 675)
12- WORLD HEALTH ORGANIZATION. WHO Exper t Commi t tee o n L e p r o s y : s i x r e p o r t . Ge n e v a , 1 9 8 8 . 5 8 9 . (WHO) . Technical report series, 768).